Direct and indirect immunofluorescence as a diagnostic adjunct in the interpretation of nonneoplastic medical lung disease

American Journal of Clinical Pathology

Volumn 119, Issue 2, 2003, Pages 279-289

  Magro, Cynthia M ^a   Morrison, Carl ^a   Pope Harman, Amy ^a   Rothrauff, Susan K ^a   Ross Jr , Patrick ^a,b  

^a THE OHIO STATE UNIVERSITY WEXNER MEDICAL CENTER   (United States)

^b OHIO STATE UNIVERSITY   (United States)

Author keywords

Direct immunofluorescence; Indirect immunofluorescence; Nonneoplastic medical lung disease

Indexed keywords

ANTIBODY; AUTOANTIBODY; ENDOTHELIAL CELL ANTIBODY; IMMUNOGLOBULIN A; PHOSPHOLIPID ANTIBODY; RHEUMATOID FACTOR; UNCLASSIFIED DRUG; COMPLEMENT; IMMUNOGLOBULIN;

ANAPHYLACTOID PURPURA; ARTICLE; BASEMENT MEMBRANE; CELIAC DISEASE; CELL STRUCTURE; CONNECTIVE TISSUE DISEASE; CONTROLLED STUDY; CRYOGLOBULINEMIA; DERMATOMYOSITIS; DIAGNOSTIC TEST; ENDOTHELIUM CELL; GRAFT REJECTION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOFLUORESCENCE; LUNG ALVEOLUS; LUNG BIOPSY; LUNG CAPILLARY; LUNG DISEASE; LUNG HEMORRHAGE; LUPUS ERYTHEMATOSUS; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; RHEUMATOID ARTHRITIS; SCLERODERMA; STAINING; ANIMAL; BIOPSY; CAPILLARY; CHEMISTRY; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOLOGY; INTERSTITIAL LUNG DISEASE; LUNG; METABOLISM; NEWBORN; PATHOLOGY; RAT; VASCULAR ENDOTHELIUM; VASCULARIZATION;

ANIMALS; ANIMALS, NEWBORN; AUTOANTIBODIES; BIOPSY; CAPILLARIES; COMPLEMENT SYSTEM PROTEINS; ENDOTHELIUM, VASCULAR; FLUORESCENT ANTIBODY TECHNIQUE, DIRECT; FLUORESCENT ANTIBODY TECHNIQUE, INDIRECT; HUMANS; IMMUNOGLOBULINS; LUNG; LUNG DISEASES, INTERSTITIAL; RATS;

EID: 85047687798     PISSN: 00029173     EISSN: None     Source Type: Journal    
DOI: 10.1309/EHUQHW6K0G41E0DX     Document Type: Article

References (53)

1. Jordon RE, Triftshauser CT, Schroeter AL. Direct immunofluorescent studies of pemphigus and bullous pemphigoid. Arch Dermatol. 1971;103:486-491.
2. Judd KP, Lever WF. Correlation of antibodies in skin and serum with disease severity in pemphigus. Arch Dermatol. 1979;115:428-432.
3. Leatherman JW, Sibley RK, Davies SF. Diffuse intrapulmonary hemorrhage and glomerulonephritis unrelated to antiglomerular basement membrane antibody. Am J Med. 1982;72:401-410.
4. Lombard CM, Colby TV, Elliot CG. Surgical pathology of the lung in anti-basement membrane antibody-associated Goodpasture's syndrome. Hum Pathol. 1989;20:445-451.
5. Beechler CR, Enquist RW, Hunt KK, et al. Immunofluorescence of transbronchial biopsies in Goodpasture's syndrome. Am Rev Respir Dis. 1980;121:869-872.
6. Kiper N, Gocmen A, Ozcelik U, et al. Long-term clinical course of patients with idiopathic pulmonary hemosiderosis (1979-1994): prolonged survival with low-dose corticosteroid therapy. Pediatr Pulmonol. 1999;27:180-184.
7. Carette S, Macher AM, Nussbaum A, et al. Severe, acute pulmonary disease in patients with systemic lupus erythematosus: ten years of experience at the National Institutes of Health. Semin Arthritis Rheum. 1984;14:52-59.
8. Schwarz M, Sutarik JM, Nick JA, et al. Pulmonary capillaritis and diffuse alveolar hemorrhage: a primary manifestation of polymyositis. Am J Respir Crit Care Med. 1995;151:2037-2040.
9. Savage CO, Winearls CG, Evans DJ, et al. Microscopic polyarteritis: presentation, pathology and prognosis. Q J Med. 1985;56:467-483.
10. Myers JL, Katzenstein AL. Wegener's granulomatosis presenting with massive pulmonary hemorrhage and capillaritis. Am J Surg Pathol. 1987;11:895-898.
11. Lesavre P. The diagnostic and prognostic significance of ANCA. Ren Fail. 1996;18:803-812.
12. Bosch X, Lopez-Soto A, Mirapeix E, et al. Antineutrophil cytoplasmic autoantibody-associated alveolar capillaritis in patients presenting with pulmonary hemorrhage. Arch Pathol Lab Med. 1994;118:517-522.
13. Markus HS, Clark JV. Pulmonary haemorrhage in Henoch-Schönlein purpura. Thorax. 1989;44:525-526.
14. Magro CM, Crowson AN. A clinical and histologic study of 37 cases of immunoglobulin A-associated vasculitis. Am J Dermatopathol. 1999;21:234-240.
15. Kathuria S, Cheifec G. Fatal pulmonary Henoch-Schönlein syndrome. Chest. 1982;82:654-656.
16. Hogan PG, Donald KJ, McEvoy JD. Immunofluorescence of lung biopsy tissue. Am Rev Respir Dis. 1978;118:537-545.
17. Douvas AS, Achten M, Tan EM. Identification of a nuclear protein (Scl-70) as a unique target of human antinuclear antibodies in scleroderma. J Biol Chem. 1979;254:10514-10522.
18. Steen VD, Ziegler GL, Rodnan GP, et al. Clinical and laboratory associations of anticentromere antibody in patients with progressive systemic sclerosis. Arthritis Rheum. 1984;27:125-131.
19. Okano Y, Steen VD, Medsger TA Jr. Autoantibody reactive with RNA polymerase III in systemic sclerosis. Ann Intern Med. 1993;119:1005-1013.
20. Moroi Y, Peebles C, Fritzler MJ, et al. Autoantibody to centromere (kinetochore) in scleroderma sera. Proc Natl Acad Sci U S A. 1980;77:1627-1631.
21. Morelli S, Ferri C, Polettini E, et al. Plasma endothelin-1 levels, pulmonary hypertension, and lung fibrosis in patients with systemic sclerosis. Am J Med. 1995;99:255-260.
22. Reimer G, Rose KM, Scheer U, et al. Autoantibody to RNA polymerase I in scleroderma sera. J Clin Invest. 1987;79:65-72.
23. Rizou C, Ioannidis JP, Panou-Pomonis E, et al. B-cell epitope mapping of DNA topoisomerase I defines epitopes strongly associated with pulmonary fibrosis in systemic sclerosis. Am J Respir Cell Mol Biol. 2000;22:344-351.
24. Steen VD, Medsger TA Jr. Severe organ involvement in systemic sclerosis with diffuse scleroderma. Arthritis Rheum. 2000;43:2437-2444.
25. Magro CM, Crowson AN. The cutaneous pathology associated with seropositivity for antibodies to SSA (Ro): a clinicopathologic study of 23 adult patients without subacute cutaneous lupus erythematosus. Am J Dermatopathol. 1999;21:129-137.
26. Magro CM, Crowson AN, Regauer S. Mixed connective tissue disease: a clinical, histologic, and immunofluorescence study of eight cases. Am J Dermatopathol. 1997;19:206-213.
27. Hirakata M, Nagai S. Interstitial lung disease in polymyositis and dermatomyositis. Curr Opin Rheumatol. 2000;12:501-508.
28. Douglas WW, Tazelaar HD, Hartman TE, et al. Polymyositis-dermatomyositis-associated interstitial lung disease. Am J Respir Crit Care Med. 2001;164:1182-1185.
29. Kissel JT, Halterman RK, Rammohan KW, et al. The relationship of complement-mediated microvasculopathy to the histologic features and clinical duration of disease in dermatomyositis. Arch Neurol. 1991;48:26-30.
30. Wiener-Kronish JP, Solinger AM, Warnock ML, et al. Severe pulmonary involvement in mixed connective tissue disease. Am Rev Respir Dis. 1981;124:499-503.
31. Hedgpeth MT, Boulware DW. Interstitial pneumonitis in antinuclear antibody-negative systemic lupus erythematosus: a new clinical manifestation and possible association with anti-Ro (SS-A) antibodies. Arthritis Rheum. 1988;31:545-548.
32. Ben-Chetrit E. Target antigens of the SSA/Ro and SSB/La system. Am J Reprod Immunol. 1992;28:256-258.
33. Reichlin M, Harley JB. Antibodies to Ro(SSA) and the heterogeneity of systemic lupus erythematosus. J Rheumatol. 1987;14(suppl 13):112-117.
34. Lanto B, Bohm F, Meffert H, et al. The cytotoxic effect of anti-Ro- (SS-A) antibodies and UVA light on human endothelial cells in vitro [in German]. Dermatol Monatsschr. 1990;176:305-311.
35. Alexander EL, Arnett FC, Provost TT, et al. Sjögren's syndrome: association of anti-Ro (SS-A) antibodies with vasculitis, hematologic abnormalities, and serologic hyperreactivity. Ann Intern Med. 1983;98:155-159.
36. Senecal JL, Chartier S, Rothfield N. Hypergamma-globulinemic purpura in systemic autoimmune rheumatic diseases: predictive value of anti-Ro(SSA) and anti-La(SSB) antibodies and treatment with indomethacin and hydroxychloroquine. J Rheumatol. 1995;22:868-875.
37. Norris DA. Pathomechanisms of photosensitive lupus erythematosus. J Invest Dermatol. 1993;100:58S-68S.
38. DeHoratius RJ, Abruzzo JL, Williams RC Jr. Immunofluorescent and immunologic studies of rheumatoid lung. Arch Intern Med. 1972;129:441-446.
39. Schwarz MI, Zamora MR, Hodges TN, et al. Isolated pulmonary capillaritis and diffuse alveolar hemorrhage in rheumatoid arthritis and mixed connective tissue disease. Chest. 1998;113:1609-1615.
40. Travis WD, Colby TV, Lombard C, et al. A clinicopathologic study of 34 cases of diffuse pulmonary hemorrhage with lung biopsy confirmation. Am J Surg Pathol. 1990;14:1112-1125.
41. Kobayashi O. An electron microscopic study of the pulmonary alveolar capillaries in idiopathic interstitial pneumonia and lungs of collagen vascular diseases [in Japanese]. Nihon Kyobu Shikkan Gakkai Zasshi. 1991;29:1007-1016.
42. Gindre D, Peyrol S, Raccurt M, et al. Fibrosing alveolitis in Wegener's granulomatosis: ultrastructural and immunohistochemical analysis of the vascular lesions. Virchows Arch. 1995;427:385-393.
43. Pittoni V, Isenberg D. Apoptosis and antiphospholipid antibodies. Semin Arthritis Rheum. 1998;28:163-178.
44. Rauch J, Subang R, D'Agnillo P, et al. Apoptosis and the antiphospholipid syndrome. J Autoimmun. 2000;15:231-235.
45. Levine JS, Koh JS, Subang R, et al. Apoptotic cells as immunogen and antigen in the antiphospholipid syndrome. Exp Mol Pathol. 1999;66:82-98.
46. Magro CM, Allen J, Ross P, et al. Microangiopathic fibrosing pneumonitis: a distinctive variant of idiopathic pulmonary fibrosis associated with antiphospholipid antibodies. American Society of Thoracic Meeting, Atlanta, GA, 2002. In press.
47. Kawanami O, Jiang HX, Mochimaru H, et al. Alveolar fibrosis and capillary alteration in experimental pulmonary silicosis in rats. Am J Respir Crit Care Med. 1995;151:1946-1955.
48. Euler HH, Zeuner RA, Beress R, et al. Monoclonal cryoantifibrinogenemia. Arthritis Rheum. 1996;39:1066-1069.
49. Patel A, Ryu J, Reed C, et al. Hypersensitivity pneumonitis: current concepts and future questions. J Allergy Clin Immunol. 2001;108:661-670.
50. Matar L, McAdams H. Hypersensitivity pneumonitis. AJR Am J Roentgenol. 2000;174:1061-1066.
51. Downey GP, Granton JT. Mechanisms of acute lung injury. Curr Opin Pulm Med. 1997;3:234-241.
52. Asimakopoulos G, Smith PL, Ratnatunga CP, et al. Lung injury and acute respiratory distress syndrome after cardiopulmonary bypass. Ann Thorac Surg. 1999;68:1107-1115.
53. Janoff A. Investigations into the biochemical mechanisms of pulmonary emphysema: effects of cigarette smoke on enzymes and anti-enzymes in the lung. Respiration. 1986;50(suppl 1):13-25.